Trial intelligence / Profile preview

Riamet versus Malarone for uncomplicated imported falciparum malaria

2010-019950-42Phase 3Active

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Apr 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in Malaria comparing Riamet arm with Malarone arm (2 arms). Primary endpoint: Need for second treatment before day 28. Started Apr 2010; status: active.

02

Drugs

artemether + lumefantrineatovaquone + proguanil
03

Conditions

Malaria

Beyond the preview

Go deeper on 2010-019950-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019950-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call